Get started
Microsoft (MSFT): Decision Point – Will It Hold or Drop?Since our last analysis on Microsoft, not much has changed in terms of price action, as it rose to $469 before getting stuck again at $416. However, there is one major development – Microsoft has formed a new trend channel. We have marked this crucial channel in red and labeled it "Must hold for more upside," emphasizing its importance. A major decision is approaching for $MSFT. Either Microsoft holds this channel, leading to a surge higher, or it loses this level, which would confirm the bearish head and shoulder pattern. We've maintained a bearish outlook on Microsoft since January 2024, and recent developments seem to support our analysis. For now, we're patiently waiting and letting the market decide. If Microsoft loses the channel, we could find initial support for wave (A) around $316-306. However, a better buying opportunity for wave II may present itself closer to $220 – though reaching this level will take some time. 🫡
NASDAQ:MSFT
by freeguy_by_wmc
PayPal (PYPL): Elliott Wave update - final target in sightSince our entry in PayPal, the stock has performed exceptionally well, respecting the Elliott wave structure and currently providing us with a return of over 35%. This price action demonstrates how effectively PayPal follows the Elliott wave count, reinforcing our bullish outlook. We have now set our stop loss at break even, allowing us to safeguard our gains while continuing to benefit from potential upward movement. During the recent wave (4), we chose not to enter, but it's important to note that the price respected the 38.2% Fibonacci retracement level precisely, indicating a strong likelihood that similar levels will be respected in future corrections. PayPal is currently advancing through wave (5), and we anticipate this wave to conclude soon. Our target for the larger wave (iii) stands at $81, with wave (5) potentially reaching up to $84. However, there is a possibility that wave (5) may conclude before reaching the wave (iii) target. Therefore, we will closely monitor the situation, keeping our alerts ready to react as needed. Once PayPal moves into the $81 target area, we will look to secure additional profits. Should the price action align with our projections, we will consider re-entering at wave (iv) for further opportunities. Until then, we let our position continue running.
NASDAQ:PYPLLong
by freeguy_by_wmc
RPD - Opportunity to get a cyber-secrurity strong stocks !Fundamentally, I follow RPD since a while ! - Good Debt/equity ratio - Revenue forecasting steadily in growth - Making CASH Technically, the stocks is pretty bad... Bearish since 2021 with a good bullish rallye in 2022, I'm waiting to enter into position for this beautiful stocks but I'll be carefull. Right now, the stocks shows us some technical inversion signals : - Double bottom, - Divergence. The better signal will be (i) the breakout of the 61.8% (Fibonnacci retracement) and (ii) the breakout of the MM200. 🚀 Wait wait wait.... ⏰
NASDAQ:RPD
by QuentinKister
ZIM intergrated shipping china. 24hr potterboxes.ZIM Intergrated shipping china. ticker ZIM. It closed on cost basis as you can see. friday oct 4. Cost basis is the middle line. $19.01 is cost basis. $16.09 would be a good stop loss for a play to the up side which might just happen because it closed on cost basis. If it opens and goes to the down side. my first target would be around $17.50 second target would be $16.05 third target. if it goes this far will be around $14.40 it should take about play to the upside would be open on $19.01 and hold that to the upside. first target $19.90 second target $20.16 third target $20.75 and then 21.98 as we should hopefully push thru this litle bit of resistance back in may thru august. well this is my take on the situation. about 15 days on the play. play it as you may. educational purposes only, not sound financial advise. Have a good day.
NYSE:ZIMLong
by potrod
AIN RupiahIntroducing AIN Rupiah: A Gateway to the Future of Decentralized Finance AIN Rupiah is the next evolution in digital assets, connecting blockchain technology with the Indonesian economy. As a tokenized version of the Rupiah, AIN Rupiah offers a seamless experience for users and businesses looking to engage in secure, efficient, and decentralized transactions. Key Features: Blockchain-Backed Security: Built on the Solana blockchain, AIN Rupiah ensures transparent and secure transactions with fast processing times and low fees. Digital Asset with Real Value: Designed to represent the stability of the Indonesian Rupiah, the AIN Rupiah is perfect for day-to-day transactions, cross-border payments, and investment diversification. Smart Contract Integration: Leverage the power of smart contracts for automatic, trustless transactions, enabling innovative decentralized financial services (DeFi) like lending, staking, and borrowing. Limited Supply, Sustainable Value: With a capped supply aligned with AIN Coin’s decentralized system, AIN Rupiah aims to maintain long-term value and utility within the ecosystem. Benefits for Users: Frictionless Transactions: Transfer funds globally in real-time without the need for traditional banking intermediaries. Low Transaction Fees: Enjoy the low-cost benefits of Solana's scalability, making everyday transactions more affordable. DeFi Integration: Participate in decentralized finance opportunities such as liquidity pools, staking, and lending, all backed by the stability of the Rupiah. Growth Potential: The AIN Rupiah is designed to grow alongside Indonesia’s digital economy, offering early adopters the chance to be part of the next financial revolution. The Vision AIN Rupiah’s launch is part of a broader mission to digitize traditional assets and enable seamless interaction between fiat currencies and the blockchain economy. Through its integration with the AIN ecosystem, AIN Rupiah will serve as a bridge, facilitating easy entry into the world of cryptocurrencies for Indonesian businesses and users while opening up opportunities for global trade and finance. Join the Revolution With AIN Rupiah, you can take part in a future where money is not only digital but smarter, faster, and more secure. Whether you're an individual user, a small business, or a large enterprise, AIN Rupiah offers a compelling solution for enhancing your financial freedom.
NYSE:AIN
by alphaindonusa
1
FFIE, a multiple x growth prospect from this bargain zone!FFIE, has been on a consistent downtrend for most of the year but that will change soon as latest QTR earnings output conveys an improving fiscal data metrics. Since having their stock split of 1:40 on Aug. 19, 2024. Price has corrected weightily from that event. Based on recent price metrics this is starting to shift already. Price has been moving horizontally from the current zone indicating a pre-surge reversal narrative. Net buys has resurfaced conveying positioning for future growth prospect. The current price range offers an attractive seeding area -- a definite bargain buy. Spotted at 2.70 TAYOR.
NASDAQ:FFIELong
by JSAL
Roivant Sciences (ROIV): A Multibagger Stock Opportunity Roivant Sciences (ROIV) is poised for significant growth with a strong pipeline, including potential blockbusters like Batoclimab and Brepocitinib in the autoimmune space. Recent deals, including the $5.2B sale of Telavant, have strengthened their balance sheet and set the stage for future profitability. Upcoming Q4 catalysts, a $1.5B buyback program, and a solid focus on pulmonary hypertension therapies make ROIV an undervalued gem at its current price. Personal Note: Hi, I'm sharing insights on stocks with strong catalysts like ROIV. Follow me for more deep dives and stock picks.
NASDAQ:ROIVLong
by InvestOhTrader
EDIT BULLISHEditas Medicine (NASDAQ: EDIT) is focused on developing CRISPR-based gene-editing technologies and has a solid pipeline for treating various genetic diseases, cancers, and autoimmune conditions. They've partnered with major players like Bristol Myers Squibb and Vertex Pharmaceuticals, boosting their credibility in the field. Editas also holds a strong patent portfolio, including exclusive licenses to key CRISPR patents from the Broad Institute and Harvard, which strengthens their ability to develop new treatments. Despite being somewhat overlooked compared to competitors like CRISPR Therapeutics, with a market cap of $461 million, EDIT has significant upside potential, targeting $7.40 and $11.60.
NASDAQ:EDITLong
by SPYDERMARKET
GE Aerospace Common Stock (GE) | Chart & Forecast SummaryKey Indicators on Trade Set Up in General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Active Sessions on Relevant Range & Elemented Probabilities; * Asian(Ranging) - London(Upwards) - NYC(Downwards) * Weekend Crypto Session # Trend | Time Frame Conductive | Weekly Time Frame - General Trend - Measurement on Session * Support & Resistance * Trade Area | Focus & Motion Ahead # Position & Risk Reward | Daily Time Frame - Measurement on Session * Retracement | 0.5 & 0.618 * Extension | 0.786 & 1 Conclusion | Trade Plan Execution & Risk Management on Demand; Overall Consensus | Buy
NYSE:GELong
by P-Ment4U
ESPR BULLISHEsperion Therapeutics (NASDAQ: ESPR), priced at $1.68 as of September 27, focuses on creating medications for cardiovascular and cardiometabolic diseases. They've launched products like NEXLETOL and NEXLIZET, which help lower LDL cholesterol in adults. Recently, 26 hedge funds held about $98.59 million in the company, with Millennium Management as the top shareholder. Esperion reported a huge revenue jump in Q2, hitting $73.8 million—up 186% from last year—and they’re on track for continued growth, even as they manage expenses. While ESPR shows promise, we think AI stocks might offer even better returns. TARGET $2.70+
NASDAQ:ESPRLong
by SPYDERMARKET
AMTX LONGAemetis (NASDAQ: AMTX) is working on technologies to replace petroleum-based products with renewable fuels, but its stock has dropped over 50% in the last year due to ongoing losses. However, it might be turning a corner, as analysts expect it to become profitable within two years and project a 90% increase in sales this year to $354 million. An analyst recently gave it a "Buy" rating with a $28 price target, highlighting strong revenue growth. While there are risks in scaling up operations and launching a sustainable aviation fuel plant, the current low stock price could make it a worthwhile investment. $3 break and ride the liquid shelf to targets above.
NASDAQ:AMTXLong
by SPYDERMARKET
CSCO short term short scalp with putsSomeone once told me never to short a stock on a bull run. My algo at that time said the stock was historically overbought, so of course I listened to the algo. I made 42% the next day. I can't say who was right or who was wrong generally, but I usually listen to the algo and I'm doing it again. My algo tells me CSCO has been overbought for 6 days (including at this point today). It has only stayed overbought for that long 3 times in the last 8 years, and the most recent time was March of '21. I'm betting that this 6 up days in a row rally takes at least a one day break in the next 1 or 2 trading days, possibly as early as today, which is why I didn't wait until the end of the day to buy. NASDAQ:AVGO had a similar but even more historically extreme setup but I didn't find it until after the market closed last night and it opened sharply lower, so I missed my chance there. I went long the Oct 4 $52 puts that cost me .25 with the stock at 52.99 and I will sell as soon as they are profitable at the end of a trading day. Maybe sooner if a drop happens this afternoon. This is market based edutainment and involves a system still undergoing testing, so it is not intended as investment advice. Particularly the short date on the expiration makes it a somewhat riskier trade.
NASDAQ:CSCOShort
by redwingcoach
4
PCRX Pacira BioSciences IncFundamentals - This stock should be prices at 30(50%) up according to the previus pricing logic with the forward earnings. - I think that this stock is pressed down because an institutional buyer that left to rapid, I don't know what the motives are. (Mabey the lost of 50% in 2 years did.) (Or if you see the traditional models, growing cashflow and earnings growing and the stock keeps decreasing every month, I would also say it's cursed. But why don't you exit way earlier then? Or is that when you get a 50% discount?) - Increase in earnings, good cashflow, good low dept. Oppinion, undervalued, excellent risk-reward. It's worth the risk of taking this trade, I took a good profit and am now scaling up. I would not recommend trading higher with 400K or call flow traders for a put option.
NASDAQ:PCRXLong
by leohanhart1996
Long AMZN (but not for long) @ 183.13Thesis: AMZN is oversold according to my algo. The end. OK just for everyone else who doesn't know that all my trades are run by my algo, I'll spice it up a little with this chart and some fundamental news just for that crowd. The blue line shows very strong long term support going back to late 2022 - tested and held 3x. The white line is short term support from the previous high before the most recent one set on Sept. 24th. While it won't matter to me if AMZN breaks through this, it would be a slight negative. I don't expect it to break this before a little run up, however. It certainly could, though. The orange line is medium term support from the August 28th low. Incidentally, that's the last time my algo considered it oversold and it proceeded to rally around 13% after that. Short term, the green triangle is a somewhat neutral triangle, but given that the bottom is steeper than the top, it was tested and held today, and the triangle is part of a strong longer-term uptrend, it gets a mildly bullish vote from me. Finally, Deloitte, Mastercard and Adobe all came out with holiday sales forecasts predicting an anywhere from 7-10% increase in online holiday sales this year vs. last year. That's fundamentally bullish for AMZN. The east coast longshoremen's strike is not especially bullish, but I imagine that most of AMZN's purchases that ship from overseas come from East Asia, rather than Europe, so I don't see that as a huge negative...YET. If it is a protracted strike and starts to affect the economy at large, then I think it's going to affect AMZN too. My trade will hopefully be a short term trade, expecting a rebound, rather than a trade long enough for the strike to seriously affect the stock. I wouldn't personally get concerned unless AMZN breaks the blue trend line with force. Even then, AMZN is not going away. If the rebound takes longer and it stays oversold, I'll add more lots and I'll sell when each lot becomes profitable. This is ideally a quick win trade, allowing me to cycle the proceeds into another idea, not a big win trade. In the last 12 months, that strategy is 19-2* on AMZN (the 2 are still open trades from early July). This is entertainment, not financial advice, so don't take it as such. DYOR and make wise investment decisions based on it. I'll update this as buys or sells are made.
NASDAQ:AMZNLong
by redwingcoach